Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin

被引:73
作者
Kanda, M [1 ]
Satoh, K [1 ]
Ichihara, K [1 ]
机构
[1] Hokkaido Coll Pharm, Dept Pharmacol, Otaru, Hokkaido 0470264, Japan
关键词
3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitor; diabete; streptozotocin; glucose tolerance test;
D O I
10.1248/bpb.26.1681
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Effects of atorvastatin and pravastatin on glucose tolerance in mildly induced diabetic rats by streptozotocin at 24 mg/kg, i.v. were studied. Non-diabetic and diabetic rats were given orally 0.5% carboxymethylcellulose (control), 8 mg/kg atorvastatin or 8 mg/kg pravastatin once a day for 6 weeks. An oral glucose tolerance test (OGTT) was carried out 1, 2, 3, and 6 weeks after the administration. The blood glucose and plasma insulin levels measured before OGTT in the diabetic rats were not different from those in the non-diabetic rats. However, the hyperglycemic response to OGTT in the diabetic rats significantly exceeded that in the non-diabetic rats. The plasma insulin increased by OGTT in the diabetic rats appeared to be lower than that in the non-diabetic rats. Statin treatments for 1 week did not modify the OGTT-induced hyperglycemia appreciably, although there were some significant differences. More than 2 weeks after administration, the blood glucose levels at several time points after a glucose intake in the atorvastatin-treated diabetic rats were significantly higher than the respective levels in the control diabetic rats. Neither atorvastatin nor pravastatin modified the OGTT-induced insulin secretion. Statins, especially atorvastatin, may influence the glucose tolerance in mildly induced diabetic rats without alterations of insulin secretion.
引用
收藏
页码:1681 / 1684
页数:4
相关论文
共 19 条
[1]
Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[2]
Atherothrombosis, inflammation, and diabetes [J].
Biondi-Zoccai, GGL ;
Abbate, A ;
Liuzzo, G ;
Biasucci, LM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (07) :1071-1077
[3]
Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation -: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin [J].
Christ, M ;
Bauersachs, J ;
Liebetrau, C ;
Heck, M ;
Günther, A ;
Wehling, M .
DIABETES, 2002, 51 (08) :2648-2652
[4]
[5]
Freeman DJ, 2001, CIRCULATION, V103, P357
[6]
STUDIES ON STREPTOZOTOCIN DIABETES [J].
GANDA, OP ;
ROSSINI, AA ;
LIKE, AA .
DIABETES, 1976, 25 (07) :595-603
[7]
THE SPONTANEOUS-DIABETES RAT - A MODEL OF NON-INSULIN DEPENDENT DIABETES-MELLITUS [J].
GOTO, Y ;
KAKIZAKI, M .
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 1981, 57 (10) :381-384
[8]
CARDIOVASCULAR RISK-FACTORS IN CONFIRMED PREDIABETIC INDIVIDUALS - DOES THE CLOCK FOR CORONARY HEART-DISEASE START TICKING BEFORE THE ONSET OF CLINICAL DIABETES [J].
HAFFNER, SM ;
STERN, MP ;
HAZUDA, HP ;
MITCHELL, BD ;
PATTERSON, JK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (21) :2893-2898
[9]
Disparity between angiographic regression and clinical event rates with hydrophobic statins [J].
Ichihara, K ;
Satoh, K .
LANCET, 2002, 359 (9324) :2195-2198
[10]
Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice [J].
Imaeda, A ;
Kaneko, T ;
Aoki, T ;
Kondo, Y ;
Nakamura, N ;
Nagase, H ;
Yoshikawa, T .
FOOD AND CHEMICAL TOXICOLOGY, 2002, 40 (10) :1415-1422